Differences in prevalence of hepatitis B virus infection and genotypes between ethnic populations in Suriname, South America.


Journal

Virology
ISSN: 1096-0341
Titre abrégé: Virology
Pays: United States
ID NLM: 0110674

Informations de publication

Date de publication:
12 2021
Historique:
received: 19 04 2021
revised: 21 09 2021
accepted: 22 09 2021
pubmed: 18 10 2021
medline: 5 1 2022
entrez: 17 10 2021
Statut: ppublish

Résumé

Epidemiological data on hepatitis B virus (HBV) are needed to benchmark HBV elimination goals. We recently assessed prevalence of HBV infection and determinants in participants attending the Emergency Department in Paramaribo, Suriname, South America. Overall, 24.5% (95%CI = 22.7-26.4%) of participants had anti-Hepatitis B core antibodies, which was associated with older age (per year, adjusted Odds Ratio [aOR] = 1.03, 95%CI = 1.02-1.04), Afro-Surinamese (aOR = 1.84, 95%CI = 1.52-2.19) and Javanese ethnicity (aOR = 1.63, 95%CI = 1.28-2.07, compared to the grand mean). 3.2% of participants were Hepatitis B surface Ag-positive, which was also associated with older age (per year, aOR = 1.02, 95%CI = 1.00-1.04), Javanese (aOR = 4.3, 95%CI = 2.66-6.95) and Afro-Surinamese ethnicity (aOR = 2.36, 95%CI = 1.51-3.71). Sex, nosocomial or culturally-related HBV transmission risk-factors were not associated with infection. Phylogenetic analysis revealed strong ethnic clustering: Indonesian subgenotype HBV/B3 among Javanese and African subgenotypes HBV/A1, HBV/QS-A3 and HBV/E among Afro-Surinamese. Testing for HBV during adulthood should be considered for individuals living in Suriname, specifically with Javanese and Afro-Surinamese ancestry.

Identifiants

pubmed: 34656809
pii: S0042-6822(21)00196-3
doi: 10.1016/j.virol.2021.09.005
pii:
doi:

Substances chimiques

Hepatitis B Antibodies 0
Hepatitis B Core Antigens 0
Hepatitis B Surface Antigens 0
Viral Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

53-61

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

M S MacDonald-Ottevanger (MS)

Scientific Research Center Suriname, Academic Hospital Paramaribo, Paramaribo, Suriname; Department of Medical Microbiology, Academic Medical Center, Amsterdam, the Netherlands. Electronic address: m.s.ottevanger@amsterdamumc.nl.

A Boyd (A)

Department of Infectious Diseases, Public Health Service Amsterdam (GGD), Amsterdam, the Netherlands; Stichting HIV Monitoring, Amsterdam, the Netherlands.

M Prins (M)

Department of Infectious Diseases, Public Health Service Amsterdam (GGD), Amsterdam, the Netherlands.

J J van der Helm (JJ)

Department of Infectious Diseases, Public Health Service Amsterdam (GGD), Amsterdam, the Netherlands.

C W R Zijlmans (CWR)

Faculty of Medical Sciences, Anton de Kom University of Suriname, Paramaribo, Suriname; Department of Environmental Health Sciences, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA; Foundation for Perinatal Interventions and Research in Suriname (Perisur), Paramaribo, Suriname.

A D Hindori-Mohangoo (AD)

Department of Environmental Health Sciences, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA; Foundation for Perinatal Interventions and Research in Suriname (Perisur), Paramaribo, Suriname.

S Harkisoen (S)

Department of Infectious Diseases, Academic Hospital Paramaribo, Suriname.

S M Hermelijn (SM)

Department of Medical Microbiology, Academic Hospital Paramaribo, Suriname.

K Brinkman (K)

Department of Infectious Diseases, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.

J Codrington (J)

Department of Clinical Chemistry, Academic Hospital Paramaribo, Suriname.

J Roosblad (J)

Department of Clinical Chemistry, Academic Hospital Paramaribo, Suriname.

S A R Kort (SAR)

Health Control, Paramaribo, Suriname.

E Th M Dams (ETM)

Department of Internal Medicine, Diakonessenhuis, Paramaribo, Suriname.

T J W van de Laar (TJW)

Department of Medical Microbiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands; Sanquin Research, Department of Donor Medicine Research, Amsterdam, the Netherlands.

S G S Vreden (SGS)

Department of Infectious Diseases, Academic Hospital Paramaribo, Suriname; Foundation for Scientific Research Suriname, Paramaribo, Suriname.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH